Please assess the completion status of the following clinical trial:

Trial Title: Predictive Value of PIIINP Urinary for the Development of Chronic Renal Failure in Patients With Cystic Fibrosis After Lung Transplantation (MUCO-IRC)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Bearer of lung transplantation (single or double lung, with or without associated cardiac transplantation)~* Suffering from cystic fibrosis~* Aged 18 and over~* With at least 6 months of transplantation~* Having a glomerular filtration rate measured by technical radionuclide \> 30 ml / min~* Having given written consent to the study Patients meeting these criteria will enter in the organic in the study (determination of PIIINP urinary)~Exclusion Criteria:~* Lung transplantation for a condition other than cystic fibrosis~* Patient refused follow-up~* Patients with advanced liver disease (conditions that interfere with the assay of PIIINP)~* Minor~* Pregnant women,~* Major Trust, benefiting from a regime of legal protection (guardianship, trusteeship, safeguarding justice.~* Patient unable to grant informed consent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).